Luffa Tablet, Orally Disintegrating
NDC Package 60986-2025-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Luffa (luffa, hydrastis canadensis, mercurius sulph. rub, allium cepa, natrum muriticum, phosphorus, eupatorium perf, sticta) tablets is a medication used as For relief of sinus symptoms; hay-fever. This formulation utilizes a tablet, orally disintegrating delivery system. Marketed by Marco Pharma International Llc., this product is identified by NDC 60986-2025.

Identification & Billing

NDC Package Code
60986-2025-2
Package Description
60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC
Product Code
60986-2025
11-Digit Billing Format
60986202502

Clinical Specifications

Proprietary Name
Luffa
Non-Proprietary Name
Luffa, Hydrastis Canadensis, Mercurius Sulph. Rub, Allium Cepa, Natrum Muriticum, Phosphorus, Eupatorium Perf, Sticta
Substance Name
Eupatorium Perfoliatum Flowering Top; Goldenseal; Lobaria Pulmonaria; Luffa Acutangula Fruit; Mercuric Sulfide; Onion; Phosphorus; Sodium Chloride
Dosage Form
Tablet, Orally Disintegrating - A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
This product is used as For relief of sinus symptoms; hay-fever.

Regulatory & Marketing

Labeler Name
Marco Pharma International Llc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
03-01-1992
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60986-2025-2 identifies a specific commercial package of 60 tablet, orally disintegrating in 1 bottle, plastic of Luffa, a human over the counter drug labeled by Marco Pharma International Llc.. This tablet, orally disintegrating is formulated for oral use and contains eupatorium perfoliatum flowering top; goldenseal; lobaria pulmonaria; luffa acutangula fruit; mercuric sulfide; onion; phosphorus; sodium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Marco Pharma International Llc. on March 01, 1992. The current certification is valid through December 31, 2027.

How is this Marco Pharma International Llc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60986202502. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
60986-2025-2
11-Digit CMS (5-4-2)
60986-2025-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.